Brain Fog News and Research

RSS

New drug combo shows promise in targeting RAS-mutant multiple myeloma

The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.

11 Dec 2023

Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis

The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results of the Phase II SUMMIT trial reported by researchers at The University of Texas MD Anderson Cancer Center.

11 Dec 2023

Long COVID patients exhibit significant cognitive slowing, new study finds

Researchers find that patients with long COVID exhibit moderate-to-severe cognitive slowing compared to controls, highlighting a distinct cognitive signature of post-COVID-19 condition.

6 Dec 2023

Study finds long-COVID symptoms fluctuate over time, challenging treatment approaches

Study reveals that over half of long Covid patients experience fluctuating symptom severities over time, highlighting the dynamic nature of the condition. The research underscores the need for adaptive healthcare interventions and self-management strategies, considering these symptom variations in long Covid cases.

30 Nov 2023

COVID-19 vaccines offer protection against long-term effects, study suggests

A new study in The BMJ explores how far vaccination averted PCC.

24 Nov 2023

MRI scans reveal distinct brain changes in people with long COVID

People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to research being presented next week at the annual meeting of the Radiological Society of North America.

22 Nov 2023

Researchers discover way to reverse brain aging caused by COVID-19

University of Queensland researchers have found a way to reverse a cellular process triggered by COVID-19 that contributes to premature aging of the brain.

22 Nov 2023

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

In a JAMA Network Open study, researchers found no evidence of neuroinflammation or blood-brain barrier dysfunction in cerebrospinal fluid markers of individuals with post-COVID-19 condition and neuropsychiatric symptoms compared to controls. The study, which assessed cytokines, chemokines, and neuroinflammation markers, suggests that persistent central nervous system immune activation may not be the primary driver of neurological long COVID symptoms.

13 Nov 2023

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Neuropsychiatric symptoms of Long COVID, including brain fog, inability to concentrate, and headache, have puzzled researchers and clinicians, who are hunting for those symptoms' causes.

10 Nov 2023

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Dutch study finds SSRIs significantly alleviate post-COVID syndrome symptoms, offering promising treatment avenues and shedding light on neurobiological mechanisms at play.

5 Nov 2023

Autoethnographic study explores utility of AI tools for accessibility

Generative artificial intelligence tools like ChatGPT, an AI-powered language tool, and Midjourney, an AI-powered image generator, can potentially assist people with various disabilities.

2 Nov 2023

New "Core Outcome Measure Set" developed to assess the severity and impact of Long COVID

Researchers have reached an agreement on how best to measure the severity and impact of Long COVID by identifying a "Core Outcome Measure Set" (COMS).

2 Nov 2023

Biomarker discovery boosts long-COVID prediction accuracy to 78.5%

Researchers identify four critical biomarkers associated with long-COVID, offering a 78.5% accuracy in predicting the condition. This discovery paves the way for diagnostic tests and offers insights into the mechanisms of persistent post-COVID symptoms.

1 Nov 2023

New insights into how menopause affects women’s lives, health, workplaces

A sweeping new paper on menopause by a UVA Health expert and collaborators highlights the profound and sometimes surprising effects the “change of life” can have on women’s lives, health, workplaces and even finances.

28 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

Can Beta-carotene boost cognitive health? Study reveals promising insights

A systematic review explores the potential of β-carotene in enhancing cognitive function, revealing its potential benefits and the importance of dietary interventions for cognitive health.

22 Oct 2023

Researchers win $5 million grant to expand access to pediatric long COVID-19 care

Researchers at Kennedy Krieger Institute have received a $5 million grant from the U.S. Department of Health and Human Services (HHS), through the Agency for Healthcare Research and Quality (AHRQ), to expand access to comprehensive care for children and adolescents with long COVID-19, particularly among underserved populations.

17 Oct 2023

Study links long COVID to gut inflammation and serotonin deficiency

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

16 Oct 2023

Investigational drug restores calcium levels in rare genetic disorder

An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and urine, as well as abnormally low levels of parathyroid hormone, which regulates blood calcium levels.

13 Oct 2023

Can a low-carb, anti-inflammatory diet be the answer to long COVID woes?

Keck Medicine of USC is conducting a clinical trial to determine if a low-carbohydrate, anti-inflammatory diet combined with a medical food raising blood ketone levels can alleviate symptoms of long COVID. The study, based on the theory that prolonged inflammation post-COVID infection causes the syndrome, aims to examine the diet's efficacy in reducing inflammation and improving patients' health.

10 Oct 2023